The Journal of Molecular Medicine, Genetics and Therapeutic Research is devoted to publishing scholarly articles that explore the intricate molecular mechanisms underlying human physiology and disease, while simultaneously promoting translational applications in genetic diagnostics, targeted therapeutics, and clinical interventions. The journal seeks to contribute meaningfully to the integration of molecular biology, medical genetics, and therapy-driven research with the ultimate aim of improving patient care through precision-based approaches. It caters to a broad audience comprising biomedical researchers, clinical geneticists, molecular biologists, pharmaceutical scientists, and healthcare professionals working at the intersection of research and medicine.

Areas of Emphasis
The journal covers a wide range of subject areas within molecular and genetic medicine, reflecting both foundational science and clinically oriented research. Key areas of emphasis include:

• Gene structure, expression, regulation, and epigenetic modifications
• Genetic basis of human diseases, including rare and complex disorders
• Molecular and genomic profiling in cancer, neurology, immunology, and cardiovascular medicine
• Pharmacogenetics and pharmacogenomics in drug development and therapeutic response
• Gene therapy technologies, including viral and non-viral vector delivery systems
• CRISPR-Cas systems, RNA editing, and gene silencing tools
• Inherited metabolic disorders and mitochondrial diseases
• Biomarkers for disease diagnosis, prognosis, and treatment monitoring
• Population genetics and genomic epidemiology in public health contexts
• Ethical, legal, and social implications (ELSI) of genetic research

The journal is especially interested in original work that bridges the gap between laboratory-based research and therapeutic innovation, highlighting its relevance to clinical practice and policy formulation.

Interdisciplinary Nature
Recognizing that modern molecular and genetic medicine thrives on interdisciplinary collaboration, the journal encourages submissions that integrate concepts from a variety of scientific domains. Manuscripts that combine experimental molecular biology with clinical insights, biostatistics, computational biology, systems medicine, pharmacology, or epidemiology are particularly welcome. Studies that involve translational pipelines—from discovery to preclinical validation to human trials—are highly valued. The journal serves as a conduit for collaboration among researchers working across specialties, supporting the evolution of personalized and evidence-based medicine.

Relevance to Global Research and Health Priorities
The Journal of Molecular Medicine, Genetics and Therapeutic Research places strong emphasis on studies that address critical global health issues through molecular and genetic approaches. Topics such as the role of genetics in infectious disease susceptibility, population-based genomic screening, emerging molecular diagnostics for underserved populations, and equity in access to genomic medicine are all within the scope of the journal. Research relevant to rare genetic diseases, regional epidemiological variations, or context-specific therapeutic responses from low- and middle-income countries is also encouraged. By fostering a platform for diverse geographic and population-level insights, the journal aims to contribute meaningfully to the global conversation on genomic and therapeutic equity.

Methodological Rigor and Innovation
Submissions must demonstrate robust scientific design and adhere to the highest standards of methodological clarity and reproducibility. The journal values transparency in research reporting, ethical compliance, and adherence to international standards in data sharing and bioethics. Studies should clearly describe methodologies used for genomic sequencing, molecular cloning, bioinformatics analysis, or therapeutic testing. Manuscripts that propose new genetic tools, diagnostic assays, or therapeutic delivery methods should be supported by comprehensive experimental validation. Meta-analyses, systematic reviews, and methodological papers that provide clarity to complex procedures or techniques are also within the scope.

Types of Manuscripts Accepted
The journal welcomes a variety of manuscript types that reflect the diversity of research and scholarship in molecular medicine and genetics. These include:

• Original research articles presenting novel data, experimental methods, or clinical findings
• Review articles offering critical summaries of existing literature, current debates, or methodological frameworks
• Short communications detailing pilot studies, protocol developments, or initial findings
• Case studies or case series involving rare genetic conditions or unusual molecular presentations
• Technical reports on genetic screening platforms, sequencing protocols, or therapeutic formulations
• Commentaries or editorials on policy developments, ethical issues, or scientific trends relevant to the field
• Special thematic submissions or invited papers aligned with contemporary issues in molecular and genetic medicine

Each submission type is expected to maintain high scholarly standards and clearly contribute to the advancement of knowledge and practice.

Target Readership and Community
The intended audience for this journal includes molecular and clinical geneticists, physicians, research scientists, clinical trial specialists, pharmacogenomic experts, biotechnologists, and graduate students involved in biomedical and therapeutic sciences. It also caters to policy advisors, academic institutions, and healthcare administrators who are involved in shaping and implementing genetic and molecular strategies for disease management. The journal fosters a sense of scholarly community by encouraging contributions from both established and emerging researchers. It supports collaborative work, interdisciplinary dialogue, and critical reflection on the application of molecular science to pressing health issues.

The Journal of Molecular Medicine, Genetics and Therapeutic Research aims to serve as a leading publication that not only promotes rigorous scientific inquiry but also facilitates the translation of molecular insights into therapeutic innovation, ultimately benefiting patient outcomes across clinical settings.